Pillstats
Rx only · Injection, Solution · Intravenous

Filgrastim

Brands: Neupogen · Releuko · Filgrastim

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers2 labelers
Packages16
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$187.18$374.35$561.53$748.71Nov 2025May 2026Jun 2026
$419.889
Latest avg · Jun 24, 2026
-36%
Since Nov 19, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amgen, Incunknown10SUPPLYING
Amneal Pharmaceuticals LLCunknown6SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.